An explorative two-way ANOVA analysis and planned post-hoc contrast analysis of the 566 investigated platelet proteins revealed that SERPINB1 (leukocyte elastase inhibitor) had the strongest dependency (p = 0.028) on lung cancer and mortality. This evidence concerns the gene SERPINB1 and lung carcinoma.